Health Sec Accepts Prostate Cancer Screening Recommendation
Singapore's Health Secretary has accepted a committee's recommendation against widespread prostate cancer screening using the Prostate-Specific Antigen (PSA) test. The decision, announced today, follows a thorough review of evidence and potential risks associated with the screening method.
The committee's assessment concluded that screening all men with the PSA test could potentially cause more harm than good. This includes the possibility of false positives leading to unnecessary biopsies and anxiety, as well as the risk of overdiagnosis and overtreatment of slow-growing cancers that may never have caused problems during a man’s lifetime.
The recommendation has been met with disappointment from prostate cancer campaigning groups, who advocate for earlier detection and improved outcomes. These groups have long argued that screening can save lives by identifying cancer at an early, more treatable stage. However, the committee's report highlighted the limitations of the PSA test and the potential for negative consequences.
The Health Secretary acknowledged the concerns of campaigners but emphasized the importance of adhering to evidence-based guidelines. The Ministry of Health will continue to support research and explore alternative screening strategies that may offer a better balance between benefits and risks. Information and resources on prostate health and early detection will remain available to the public through healthcare providers and relevant organizations.
Prostate cancer is the second most common cancer among Singaporean men. While the decision not to implement widespread PSA screening may be controversial, it reflects a commitment to ensuring that screening programs are safe, effective, and provide the greatest benefit to the population. The Ministry of Health encourages men to discuss their individual risk factors and screening options with their doctors.
